Grantham, Mayo, Van Otterloo & Co (GMO)’s Comerica CMA Stock Holding History
Bought
Maintained
Sold
Other funds holding CMA
Grantham, Mayo, Van Otterloo & Co (GMO)'s CMA Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Comerica (CMA) in Q1 2026, closing a stake of 423,815 shares — an estimated $36.8M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CMA in Q2 2013 and held it in 15 quarters. The position peaked at $36.8M in Q4 2025. 4 funds tracked by Wall St. Rank hold CMA as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Comerica position as of Q1 2026 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 423,815 Comerica shares in Q1 2026, an estimated $36.8M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Comerica in Q2 2013 and held it in 15 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Comerica position peaked at $36.8M in Q4 2025.
- 4 funds tracked by Wall St. Rank held Comerica as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.